personalized medicine Aug 22, 2022 Pillar Biosciences Receives China Approval for Colon Cancer Companion Diagnostic Assay Jul 21, 2022 Imagia Canexia Health, Anwa Medical Partner to Offer Liquid Biopsy in Middle East, North Africa Jul 19, 2022 Geneseeq, Brazil's Hospital de Base Partner to Build Sequencing Lab for Cancer Patient Testing Jul 7, 2022 ESMO Releases Guidelines for Liquid Biopsy Testing in Cancer Patients Jun 17, 2022 Tempus, Intermountain Healthcare Strike Precision Cancer Research Alliance May 18, 2022 Avalon GloboCare, Lu Daopei Hematology Institute Partner to Develop Cell Therapy CDx May 11, 2022 Oncocyte Q1 Revenues Rise 27 Percent on DetermaRx Activity May 11, 2022 Castle Bio Adds New Outcome Data for Melanoma Assay, Shares Early Info on Skin Disease Test Premium May 11, 2022 Guidelines Update Supports Use of Genomic Tests in Early Prostate Cancer Management May 6, 2022 Tempus to Provide NGS Cancer Tests to US Department of Veterans Affairs May 4, 2022 NGeneBio Receives CE-IVD Mark for NGS-Based Cancer Panel May 2, 2022 Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital Apr 27, 2022 Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines Apr 11, 2022 NewStem Files FDA De Novo Submission, Gets CE Mark for Stem Cell Mutational Analysis Software Apr 7, 2022 Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study Premium Mar 25, 2022 Roche, Bristol Myers Squibb Partner on Digital Pathology Algorithms, Assays for Cancer Diagnosis Mar 9, 2022 Reveal Genomics Introduces HER2DX Breast Cancer Test in Europe, Plans US Expansion Premium Feb 28, 2022 Legislators Introduce Bill Seeking to Raise PGx Awareness, Adoption Premium Feb 2, 2022 President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate Nov 24, 2021 HER2 Treatments See New Milestones in Colorectal Cancer, With Liquid Biopsy Identifying Responders Premium Load More Breaking News Tesis Biosciences to Develop miRNA Biomarkers for mTBI Diagnosis In Brief This Week: Abbott, Danaher, Lucira Health, Novacyt Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug Quest Diagnostics Enters Lab Deal With Maine Healthcare System Northern Light Health Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance Diazyme Gets FDA Emergency Use Authorization for SARS-CoV-2 Antibody Test
